Long-Term Safety Study of Infliximab in Moderate-To-Severe Chronic Obstructive Pulmonary Disease

Respiratory Medicine - United Kingdom
doi 10.1016/j.rmed.2012.11.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Differences in Symptom Burden Among Patients With Moderate, Severe, or Very Severe Chronic Obstructive Pulmonary Disease

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2016English

Erratum To: Comparative Study of the Safety of Regadenoson Between Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease and Asthma

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2013English

Pulmonary Complications After Abdominal Surgery in Patients With Mild-To-Moderate Chronic Obstructive Pulmonary Disease

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2016English

Study of OSA in Chronic Obstructive Pulmonary Disease

Journal of Medical Science And clinical Research
2017English

Chronic Obstructive Pulmonary Disease

New England Journal of Medicine
Medicine
2000English

The Lung Tissue Microbiota of Mild and Moderate Chronic Obstructive Pulmonary Disease

Microbiome
Microbiology
2018English

Cost-Effectiveness of Tiotropium Versus Glycopyrronium in Moderate to Very Severe Chronic Obstructive Pulmonary Disease in Canada, Spain, Sweden, and the UK

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2016English

Chronic Obstructive Pulmonary Disease

JAMA - Journal of the American Medical Association
Medicine
2008English

Chronic Obstructive Pulmonary Disease

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy